ArticleHaematologica2016

FDG-PET as a biomarker for early response in diffuse large B-cell lymphoma as well as in Hodgkin lymphoma? Ready for implementation in clinical practice?

Josée M Zijlstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.